Biofarm sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-07-15
Share capital
6,006,000.00 PLN
Average employment (FTE)
492.3 (2025)
Activity description

Biofarm is one of Poland’s largest pharmaceutical companies, based in Poznan and producing medicines, dietary supplements and preparations for pharmacy and non-pharmacy markets. The company operates its own Research and Development Centre, has 180 registered products, and manufactures more than 93% of its medicines at its Poznan production facility.

Registered address
Wałbrzyska 13, 60-198 Poznań, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-24854-57400-IDUIB-34

Financials

Revenue history (in m)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

From the notes

Current income tax (CIT due)$8,278,732
Profit allocationDividend and reserves
R&D costs$543,826
Management board pay$336,702
Parent companyBiofarm Sp. z o.o.
Shares in other companies

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 87 days late). All were audited by a statutory auditor.

  • 202507/07/2026
  • 202403/07/2025
  • 202312/07/2024
  • 202211/07/2023
  • 202110/10/2022
  • 202023/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing524 / 24,570
Top 2.1%
City · Poznań51 / 11,708
Top <1%
Voivodeship · Wielkopolskie193 / 30,871
Top <1%
Country · Poland1,583 / 297,266
Top <1%

Results vs industry

Revenue
This companyUSD 143.42mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 34.27mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 95.34mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 127.72mMedianUSD 897.46kAverageUSD 31.52m

Websites

The company has 4 websites. Most of them run on WordPress. The sites are available in: Polish, English and Ukrainian. The sites target these markets: United States and Ukraine. Traffic on the sites is measured with Google Analytics.

  • biofarm.plBiofarm | Producent leków, firma farmaceutyczna z Poznania
    Google AnalyticsGoogle Tag ManagerApache
  • actigraforte.plStrona główna – ActiGra Forte
    WordPress 7.1Yoast SEOApache
  • cemaxforte.plCemax Forte Biofarm – suplement diety
    WordPress 7.1ElementorGoogle Tag ManagerApache

Public procurement

The company is the contractor in one public sector contract, worth USD 1.41k.

SubjectAmount
Medication donation
$1,413

Trademarks

The company holds 317 active trademarks registered with the Polish Patent Office. 8 applications are pending. 512 marks have expired or were not registered. The first mark was filed in 1991.

MarkNumberClassesStatusProtected until
Aciviran (word)Z.5990275Protected Mar 5, 2036
Gliforin (word)Z.5984895Protected Feb 24, 2036
Novelio (word)Z.5971715Protected Jan 27, 2036
Fenalid Duo (word)Z.5972855Protected Jan 27, 2036
Nevellia (word)Z.5971725Protected Jan 27, 2036
MarkProtected until
Aciviran (word)Mar 5, 2036
Gliforin (word)Feb 24, 2036
Novelio (word)Jan 27, 2036
Fenalid Duo (word)Jan 27, 2036
Nevellia (word)Jan 27, 2036

Job offers

The company has its own careers page: biofarm.pl/kariera.

Authorized Representatives

Alena Krzyżaniak age 45 – Management Board Member
Radosław Grzyb age 40 – Attorney-in-fact (sole)
Jarosław Pieczuro age 52 – Management Board Member

Manner of representation

If the company’s management board is a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations and sign on behalf of the company.

Supervisory board

Patrycja Szwarczyńska-Brown – Supervisory Board Member
Grażyna Małgorzata Denkowska-Szwarczyńska age 75 – Supervisory Board Member
Waldemar Jarosław Szwarczyński age 73 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
1,201$590,443.0036.3939%
1,499$736,947.6045.4242%
Others
600$294,975.6918.1819%

Waldemar Jarosław Szwarczyński and Grażyna Małgorzata Denkowska Szwarczyńska hold a combined 81.8% – the ownership structure indicates family control.

Beneficial owners

Person

Subsidiaries

NameStake
Biofarm - Hurt sp. z o.o.
99.9689%

Bank accounts

Registered as a VAT taxpayer on 1996-01-03.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 1.2M
Investment property
PLN 509.5K

Secured liabilities

Type
Registered pledge over a machine
Registered pledge over inventory

MSiG notices

Publication dateEvent
May 10, 2017Return of additional payments

Public aid

9 public aid cases recorded, with a total value of $1,355,210.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$15,900
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$17,329
Regional investment aid
$78,969

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Adamed Pharma S.A.
Aflofarm Farmacja Polska sp. z o.o.
Zentiva Polska sp. z o.o.
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.
Farmak International sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
SUN-Farm sp. z o.o.
Poznańskie Zakłady Zielarskie Herbapol S.A.
Tactica Pharmaceuticals sp. z o.o.

Change history

DateEvent
2024-04-05Share capital increase
2015-08-19Share capital increase
2002-07-15Entered in the register

FAQ

Last updated: 2026-10-07